This announcement is a separate document:
海南葫芦娃药业集团股份有限公司与中信建投证券股份有限公司关于海南葫芦娃药业集团股份有限公司向不特定对象发行可转换公司债券申请文件的审核问询函的回复（修订稿）（2023年度财务数据更新版）
Response from Hainan Huluwa Pharmaceutical Group Co., Ltd. and CITIC Construction Investment Securities Co., Ltd. to the review inquiry letter of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the application documents of Hainan Huluwa Pharmaceutical Group Co., Ltd. to issue convertible corporate bonds to unspecified targets (revised draft) (2023 financial data update)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.